Management of Male Breast Cancer: The Journey so Far and Future Directions

Male breast cancer is now shown to be a unique entity and should be considered as a distinct disease. Given the relatively smaller number of cases, randomized controlled trials for treatment are extremely limited and majority of practices are derived from female breast cancer studies. This paper rev...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabih, Quratulain (Anna), Young, Jessica, Takabe, Kazuaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734504/
https://www.ncbi.nlm.nih.gov/pubmed/35059080
http://dx.doi.org/10.14740/wjon1418
_version_ 1784628034098167808
author Sabih, Quratulain (Anna)
Young, Jessica
Takabe, Kazuaki
author_facet Sabih, Quratulain (Anna)
Young, Jessica
Takabe, Kazuaki
author_sort Sabih, Quratulain (Anna)
collection PubMed
description Male breast cancer is now shown to be a unique entity and should be considered as a distinct disease. Given the relatively smaller number of cases, randomized controlled trials for treatment are extremely limited and majority of practices are derived from female breast cancer studies. This paper reviews available literature on surgical, radiation, and systemic therapies for male breast cancer, and discusses current practice recommendations.
format Online
Article
Text
id pubmed-8734504
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elmer Press
record_format MEDLINE/PubMed
spelling pubmed-87345042022-01-19 Management of Male Breast Cancer: The Journey so Far and Future Directions Sabih, Quratulain (Anna) Young, Jessica Takabe, Kazuaki World J Oncol Review Male breast cancer is now shown to be a unique entity and should be considered as a distinct disease. Given the relatively smaller number of cases, randomized controlled trials for treatment are extremely limited and majority of practices are derived from female breast cancer studies. This paper reviews available literature on surgical, radiation, and systemic therapies for male breast cancer, and discusses current practice recommendations. Elmer Press 2021-12 2021-12-08 /pmc/articles/PMC8734504/ /pubmed/35059080 http://dx.doi.org/10.14740/wjon1418 Text en Copyright 2021, Sabih et al. https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Sabih, Quratulain (Anna)
Young, Jessica
Takabe, Kazuaki
Management of Male Breast Cancer: The Journey so Far and Future Directions
title Management of Male Breast Cancer: The Journey so Far and Future Directions
title_full Management of Male Breast Cancer: The Journey so Far and Future Directions
title_fullStr Management of Male Breast Cancer: The Journey so Far and Future Directions
title_full_unstemmed Management of Male Breast Cancer: The Journey so Far and Future Directions
title_short Management of Male Breast Cancer: The Journey so Far and Future Directions
title_sort management of male breast cancer: the journey so far and future directions
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734504/
https://www.ncbi.nlm.nih.gov/pubmed/35059080
http://dx.doi.org/10.14740/wjon1418
work_keys_str_mv AT sabihquratulainanna managementofmalebreastcancerthejourneysofarandfuturedirections
AT youngjessica managementofmalebreastcancerthejourneysofarandfuturedirections
AT takabekazuaki managementofmalebreastcancerthejourneysofarandfuturedirections

Ejemplares similares